DelveInsight's Hereditary Transthyretin Amyloidosis Market Insights report includes a comprehensive understanding of current ...
A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin greatly reduced transthyretin levels in patients with ...
Acoramidis reduced the cumulative burden of cardiovascular outcomes at 30 months in patients with transthyretin amyloid ...
PITTSBURGH (KDKA) -- Amyloidosis is a rare condition that used to almost always be fatal, but doctors are finally making progress in treating it. "I had so many symptoms, and I really didn't think ...
University College London's National Amyloidosis Center leads a multinational team reporting that a single infusion of an in ...
Amyloidosis is classified into three main forms depending on the cause of the condition. The condition is also referred to as either localized when only one site of the body is affected, or systemic ...
Interviewer: Amyloidosis is a rare and possibly debilitating disease, which affects about 4,000 people a year in the United States. If left untreated, the disease can cause severe organ damage, so ...
The National Institutes of Health has classified amyloidosis as a rare condition — one that affects fewer than 200,000 Americans. (1) While most experts who study the disease say it’s presumably much ...
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that longer-term data from the ...
Q: Which doctor should I consult for amyloidosis? A: You may initially consult a physician who may refer you to other specialist doctors such as an oncologist (doctor who treats cancer) or a bone ...
Cardiac amyloidosis is not nearly as rare as one might think, and with effective treatments finally emerging in recent years, there’s a need to increase awareness of the condition to allow for earlier ...
Dr. Jose Nativi is a cardiologist and director of the amyloidosis program at University of Utah Health Care and Huntsman Cancer Institute. He explains what amyloidosis is and why it’s so tricky to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback